Teva's bid to block generic copaxone rejected
TEVA drug pipeline, global patents
Patent expiry dates for biologicals: 2016 update - GaBI Journal
Patent expiry dates for biologicals: 2017 update - GaBI Journal
Does Drug Patent Evergreening Prevent Generic Entry? – DrugPatentWatch - Make Better Decisions
Patent expiry dates for best-selling biologicals - GaBI Journal
30 Years Of Generics
Patent Docs: Top Drugs Losing Patent Exclusivity in 2021
List - 107 Drug Patents Expiring Between 2023 to 2025 - GreyB
Patent expiry dates for biologicals: 2017 update - GaBI Journal
Patent expiry dates for biologicals: 2016 update - GaBI Journal
Patent expiry dates for biologicals: 2018 update - GaBI Journal
Monthly price reduction of generic drugs after patent loss U.S. 2015 | Statista
Drug Patent Expirations and the “Patent Cliff”
Teva and Eagle Allege Infringement of 14 Cancer Drug Patents by Accord's Proposed Generic - IP News Shots
Generic drug - Wikipedia
Celgene Settles U.S. Patent Litigation for Revlimid | Fortune
India's drug industry to touch $48 billion by 2018
Court refuses injunctions in pharma patent case
Patexia - Pfizer vs Teva was a big case between generic and brand drugmakers, and was the first time when damages were paid for the creation and selling of a generic brand
Legitimate patent extension or patent system abuse? | Pharmaceutical Patent Analyst
Teva generics revenue by region 2016-2020 | Statista
Patent expiry dates for biologicals: 2017 update - GaBI Journal
One, two, three, gone: Teva loses third patent on new Copaxone formula | FiercePharma
Top 5 expired blockbuster drugs - Clinical Trials Arena
Tadalafil patent destroyed in further blow for ICOS and Eli Lilly - JUVE Patent
